Medicine in Omics is a peer-reviewed open access journal. The journal publishes human health related original omics research, including genomics, proteomics, epigenomics metabolomics, lipidomics, peptidomics, metagenomics, microbiomics, pharmacogenomics, toxicogenomics etc., with the focus on disease etiology, prevention, diagnosis, treatment and therapy, prognosis and monitoring.Article types accepted include, but are not limited to, original research articles, reviews, case reports, short communications and editorials.Benefits to authorsWe provide many author benefits, such as APC waivers for accepted manuscripts submitted by 31 December 2020, certificate of publication for your article and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.
Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2022 impact factor is 12.4.Visit the Cell Press website for more information about Molecular Therapy - http://www.cell.com/molecular-therapy-family/home
Next Bioengineering is a peer-reviewed, open access journal publishing cutting-edge research of relevance to the bioengineering community.The journal is part of the Next family, a new suite of multidisciplinary open access journals from Elsevier spanning all branches of research. Managed by our dedicated team of full-time inhouse Editors, Next Energy offers authors speed, consistency, innovation, flexibility and ease of submission, while providing readers in the field with seamless access.Next Bioengineering aims to cover all aspects of biological engineering, for research and application. The journal welcomes submissions that explore novel bioengineering approaches, from fundamental research on biomaterials and tissue engineering to the development of bio-inspired technologies and medical devices.Next Bioengineering provides authors with a rigorous peer review process to ensure high-quality publications that contribute to the advancement of bioengineering research. The journal offers a platform for researchers to share their innovative work and inspire the next generation of bioengineers.Our Editors welcome submissions that push the boundaries of bioengineering research and contribute to the development of transformative technologies for healthcare, biotechnology, and beyond.Our Editors welcome submissions on bioengineering issues including but not limited to:Biomaterials and biocompatible materialsTissue engineering and regenerative medicineBiomechanics Biofluid mechanicsBioinformatics and computational biologyBiomedical imaging and sensing technologiesBio-inspired robotics and prostheticsDrug delivery systems and nanomedicineSynthetic biology Genetic engineeringBiomedical devices and instrumentationBioprinting
